The std diagnostics global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
STD Diagnostics Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The std diagnostics market size has grown rapidly in recent years. It will grow from $9.25 billion in 2023 to $10.19 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to epidemiological trends, healthcare infrastructure development, pharmaceutical developments, sexual education programs, demographic shifts.
The std diagnostics market size is expected to see strong growth in the next few years. It will grow to $14.82 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to personalized medicine trends, healthcare access improvements, population health strategies, telemedicine and digital health, rising incidence of stds. Major trends in the forecast period include point-of-care testing (poct) advancements, home testing kits,multiplex testing, targeted marketing and outreach, pre-exposure prophylaxis (prep) programs, rising incidence rates.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Scope Of STD Diagnostics Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
STD Diagnostics Market Overview
Market Drivers –
The growing prevalence of STDs is driving the STD diagnostics market forward. STDs (sexually transmitted diseases) are infectious diseases that are transmitted from an infected person to a normal person through sexual contact. The STD diagnostics provide an efficient analysis and testing of this infection. For instance, in 2022, according to the World Health Organization (WHO), an international agency of the United Nations focusing on improving international public health, more than 1 million sexually transmitted infections are acquired every day globally. In addition, there are about 374 million new infections each year, with 1 of 4 STDs, chlamydia, gonorrhea, syphilis, and trichomoniasis. As a result, the rising prevalence of STDs propels the STD diagnostics market.
Market Trends –
The advancement in STD diagnostics is a key trend in STD diagnostic market. Major players are upgrading the testing facilities and techniques to provide a better and fast diagnosis of sexually transmitted diseases. For instance, in May 2022, BD (Becton, Dickinson, and Company), a US-based medical technology company launched a fully automated, high-throughput infectious disease molecular diagnostics platform, known as BD CORTM MX/PX System. This platform unifies and automates the molecular laboratory workflow, from sample processing to diagnostic test results. The first test made accessible on the new platform is the BD CTGCTV2 molecular assay, which is a single test that can identify the three most common non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).
The std diagnostics market covered in this report is segmented –
1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types
2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare
Get an inside scoop of the std diagnostics market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp
Regional Insights –
North America was the largest region in the STD diagnostics market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the std diagnostics market report are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech plc, Binx Health Inc., Lybrate Inc., NOWDiagnostics Inc., Alere Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Inflammatix Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy
1. Executive Summary
2. STD Diagnostics Market Report Structure
3. STD Diagnostics Market Trends And Strategies
4. STD Diagnostics Market – Macro Economic Scenario
5. STD Diagnostics Market Size And Growth
…..
27. STD Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
